Fighting deadly pathogens and anti-microbial resistant bacteria (AMR) is a major global challenge. Our MedTech startup, BioKubes™ registered in Delaware, USA, has developed an advanced rapid bacteria identification technology.

 

Lessening AMR’s impact will require incremental contributions from the global research community. Our fully automated platform combines advanced bioimaging, robotics, and machine learning classification to produce rapid cost-effective bacteria screenings.

 

The BioKubes™ user-friendly design allows microbiology and non-microbiology researchers (genomics, pharma, environment, medicine) to conduct highly accurate multi-dimensional bacteria analysis.

 

BioKubes' expansion plan will produce new hardware/software applications developed internally or in partnership with research institutions and innovative startups in an open innovation partnership.